The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of CB-103, a novel first-in-class inhibitor of the CSL-NICD gene transcription factor complex in human cancers.
 
Elena Lopez Miranda
No Relationships to Disclose
 
Anastasios Stathis
Consulting or Advisory Role - Bayer (Inst); Lilly (Inst)
Research Funding - ADC Therapeutics (Inst); Bayer (Inst); Cellestia Biotech (Inst); Lilly (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; PharmaMar
 
Dagmar Hess
No Relationships to Disclose
 
Fabricio Racca
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; Roche
Expert Testimony - Pharmore Research; Psyma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Doris Quon
No Relationships to Disclose
 
Jordi Rodon
No Relationships to Disclose
 
Omar Saavedra Santa Gadea
Travel, Accommodations, Expenses - Kyowa Kirin; MSD
 
Jose Manuel Perez Garcia
Consulting or Advisory Role - Lilly; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Paolo Nuciforo
Honoraria - Bayer; MSD Oncology; Novartis
Consulting or Advisory Role - Bayer; MSD Oncology
Travel, Accommodations, Expenses - Novartis
 
Ana Vivancos
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Guardant Health (Inst); Incyte (Inst); Merck (Inst); Roche (Inst); Sysmex (Inst)
Research Funding - Bristol Meyers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - FERRER (Inst)
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Daiichi Sankyo; Eisai; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Athenex; Bioasis; Biothera; Boehringer Ingelheim; Celgene; Cellestia Biotech; Clovis Oncology; Daiichi Sankyo; ERYTECH Pharma; GlaxoSmithKline; Kyowa Kyrin; Leuko; Lilly; Merck Sharp & Dohme; Merus; Polyphor; Roche; Seagen; SERVIER
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Eisai (Inst); Guardant Health (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Piqur (Inst); Puma Biotechnology (Inst); Queen Mary university of London (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Eisai; Novartis; Pfizer; Roche
 
Renata Ferrarotto
Consulting or Advisory Role - Bicara Therapeutics; Carevive Systems; Intellisphere; Prelude Therapeutics; Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); Ayala Pharmaceuticals (Inst); Ayala Pharmaceuticals (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Merck Serono (Inst); Pfizer/EMD Serono (Inst); Prelude Therapeutics (Inst); Prelude Therapeutics (Inst)
 
Oliver Schönborn-Kellenberger
Employment - Cogitars
Leadership - Cogitars
Consulting or Advisory Role - Cellestia Biotech
 
Michele Vigolo
Employment - Cellestia Biotech
Stock and Other Ownership Interests - Cellestia Biotech
 
Maria Bobadilla
Employment - Cellestia Biotech
Stock and Other Ownership Interests - Cellestia Biotech; Novartis; Roche
 
Laura Beni
Employment - Cellestia Biotech
Stock and Other Ownership Interests - Cellestia Biotech
 
Rajwinder Lehal
Employment - Alexion Pharmaceuticals (I); Cellestia Biotech
Leadership - Cellestia Biotech
Stock and Other Ownership Interests - Cellestia Biotech
Patents, Royalties, Other Intellectual Property - Cellestia Biotech
 
Michael Pascal Bauer
Employment - Cellestia Biotech
Leadership - Cellestia Biotech
Stock and Other Ownership Interests - Cellestia Biotech
Patents, Royalties, Other Intellectual Property - Cellestia Biotech
 
Florian D. Vogl
Employment - Cellestia Biotech; Rainier Therapeutics
Leadership - Cellestia Biotech
Stock and Other Ownership Interests - Amgen
 
Elena Garralda
Consulting or Advisory Role - Alkermes; Anaveon; Boehringer Ingelheim; Bristol-Myers Squibb; Ellipses Pharma; Janssen; MAB Discovery; NeoMed; Roche; Seagen; TFS; Thermo Fisher Scientific
Speakers' Bureau - Lilly; MSD; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune; Novartis; Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Glycotope GmbH; Menarini; Merck Sharp & Dohme